Evidence map›Paper›PMID 41168462›Full record

ArticleThe EMBO journal2025

Auto-inhibition of PRC2 by the broadly expressed long isoform of AEBP2.

Marlena Mucha, Zhihao Lai, Nicholas J McKenzie, Francesca Matrà, Marion Boudes, Sarena F Flanigan, Maria Teresa Alejo-Vinogradova, Craig Monger, Qi Zhang, Darragh Nimmo and 15 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Marlena Mucha *Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0001-9009-3383
Zhihao Lai *Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0003-4416-0623
Nicholas J McKenzie *Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Francesca Matrà *Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Marion BoudesDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0003-2577-710X
Sarena F FlaniganDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Maria Teresa Alejo-VinogradovaDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, 6525 GA, The Netherlands.
Craig MongerSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Qi ZhangDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0003-1121-8817
Darragh NimmoSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Evan HealySmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Ademar J SilvaSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Daniel AngelovSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0001-5529-4913
David M ReckSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.ORCID http://orcid.org/0009-0000-3862-8440
Gráinne HollandSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0003-1567-4465
Zeynep Eda AtmacaDepartments of Biochemistry and Molecular Medicine, and Stem Cell and Regenerative Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.ORCID http://orcid.org/0009-0001-0922-2094
Helen E KingEMBL Australia, Garvan Institute of Medical Research, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-3082-7653
Maeve HamiltonSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Eleanor GlancySmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
James NolanSmurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Robert J WeatherittEMBL Australia, Garvan Institute of Medical Research, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-3716-1783
Oliver BellDepartments of Biochemistry and Molecular Medicine, and Stem Cell and Regenerative Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.ORCID http://orcid.org/0000-0002-7639-5948
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, 6525 GA, The Netherlands.ORCID http://orcid.org/0000-0003-0836-6894
Chen Davidovich *Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia. chen.davidovich@monash.edu.ORCID http://orcid.org/0000-0002-1085-6094
Adrian P Bracken *Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland. adrian.bracken@tcd.ie.ORCID http://orcid.org/0000-0002-1547-9443

Funding

Epigenetic Maintenance of Neural Cell IdentityR01MH122565 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BELL, OLIVER · 2021 to 2025
$2.1M
Department of Education and Training | Australian Research Council (ARC) DP190103407Department of Education and Training | Australian Research Council (ARC) DP250104894Department of Education and Training | Australian Research Council (ARC) FT240100821Federal Government | DHAC | National Health and Medical Research Council (NHMRC) APP1162921,APP1184637,APP2011767,APP2020900Federal Government | DHAC | National Health and Medical Research Council (NHMRC) APP1196365HHS | NIH | National Institute of Mental Health (NIMH) R01MH122565Irish Research Council for Science, Engineering and Technology (IRCSET) IRCLA/2019/21NIMH NIH HHS R01 MH122565Science Foundation Ireland (SFI) 15/IA/3104Science Foundation Ireland (SFI) SFI/16/IA/4562
6 · The paper itself

Abstract

Polycomb Repressive Complex 2 (PRC2) is an essential chromatin regulator responsible for mono-, di- and tri-methylating H3K27. Control of PRC2 activity is a critical process in development and disease, yet no inhibitory cofactor has been identified in somatic cells. Here, we show that the alternative isoforms of its accessory subunit AEBP2, namely AEBP2

Indexed as

Polycomb Repressive Complex 2AnimalsCryoelectron MicroscopyGene Expression Regulation, DevelopmentalHumansMiceProtein IsoformsPolycomb Repressive Complex 2Protein IsoformsAEBP2Cryo-EMPolycombPRC2Trithorax

Identifiers

PMID41168462
PMCPMC12669776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.